HST Global, Inc. (HSTC) stock
HSTCOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2024, quarter ended Sep 30, 2024Last filing: 10-K on Nov 3, 2025
$0.70+0.57 (+423.56%)
Close on Oct 19, 2026Market cap $28.78MP/E –Yield –
HST Global r&d expenses
Research and development expenses are spending on new products and technology.
No r&d expenses figures for HST Global
HST Global has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?